Evidence map›Paper›PMID 24532689›Full record

ArticleGenes & development2014

The Rad50 hook domain regulates DNA damage signaling and tumorigenesis.

Ramon Roset, Akiko Inagaki, Marcel Hohl, Fabienne Brenet, Julien Lafrance-Vanasse, Julian Lange, Joseph M Scandura, John A Tainer, Scott Keeney, John H J Petrini

Abstract read
In one paragraph

Article in Genes & development, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Meiotic Recombination Defects and Premature Ovarian Insufficiency.Frontiers in cell and developmental biology · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ramon RosetMolecular Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA;
Akiko Inagaki
Marcel Hohl
Fabienne Brenet
Julien Lafrance-Vanasse
Julian Lange
Joseph M Scandura
John A Tainer
Scott Keeney
John H J Petrini

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Transcription-Coupled & Replication-Associated Excision RepairP01CA092584 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI John A. Tainer · 2001 to 2026
$89.6M
ROLES OF MRELL AND RAD50 IN THE DNA DAMAGE RESPONSER01GM056888 · NIGMS · UNIVERSITY OF WISCONSIN MADISON · PI PETRINI, JOHN HJ · 1998 to 2019
$8.6M
Mre11/Rad50 Structural Biology for DNA Damage ResponsesR01CA117638 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI RUSSELL, PAUL, TAINER, JOHN A. · 2005 to 2019
$5.6M
PI 3-KINASE AND KIT RECEPTOR SIGNALINGR01HL055748 · NHLBI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI BESMER, PETER · 1997 to 2012
$4.0M
Role of Spo11 and recombination in mouse meiosisR01GM105421 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI JASIN, MARIA, KEENEY, SCOTT · 2013 to 2016
$2.4M
Identification of vascular-derived signals for alveolar lung repairR01HL119872 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI RAFII, SHAHIN · 2013 to 2016
$2.3M
Genome-wide Identification of DNA Methylation Biomarkers in AMLR21CA159175 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI SCANDURA, JOSEPH MICHAEL · 2012 to 2013
$410k
FASEB SRC on Genetic Recombination and Genome RearrangementsR13CA162528 · NCI · FEDERATION OF AMER SOC FOR EXPER BIOLOGY · PI PETRINI, JOHN HJ · 2011 to 2011
$5k
Howard Hughes Medical InstituteNCI NIH HHS CA159175NCI NIH HHS P01 CA092584NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA117638NCI NIH HHS R13 CA162528NCI NIH HHS R21 CA159175NHLBI NIH HHS HL055748NHLBI NIH HHS HL119872NHLBI NIH HHS R01 HL055748NHLBI NIH HHS R01 HL119872NIGMS NIH HHS R01 GM056888NIGMS NIH HHS R01 GM105421NIGMS NIH HHS R01-GM56888
6 · The paper itself

Abstract

The Mre11 complex (Mre11, Rad50, and Nbs1) is a central component of the DNA damage response (DDR), governing both double-strand break repair and DDR signaling. Rad50 contains a highly conserved Zn(2+)-dependent homodimerization interface, the Rad50 hook domain. Mutations that inactivate the hook domain produce a null phenotype. In this study, we analyzed mutants with reduced hook domain function in an effort to stratify hook-dependent Mre11 complex functions. One of these alleles, Rad50(46), conferred reduced Zn(2+) affinity and dimerization efficiency. Homozygous Rad50(46/46) mutations were lethal in mice. However, in the presence of wild-type Rad50, Rad50(46) exerted a dominant gain-of-function phenotype associated with chronic DDR signaling. At the organismal level, Rad50(+/46) exhibited hydrocephalus, liver tumorigenesis, and defects in primitive hematopoietic and gametogenic cells. These outcomes were dependent on ATM, as all phenotypes were mitigated in Rad50(+/46) Atm(+/-) mice. These data reveal that the murine Rad50 hook domain strongly influences Mre11 complex-dependent DDR signaling, tissue homeostasis, and tumorigenesis.

Indexed as

DNA DamageAnimalsAtaxia Telangiectasia Mutated ProteinsCarcinogenesisCell Cycle CheckpointsDNA-Binding ProteinsDNA RepairDNA Repair EnzymesGerm CellsMiceMRE11 Homologue ProteinMutationPhenotypeProtein Structure, TertiarySignal TransductionAtaxia Telangiectasia Mutated ProteinsDNA-Binding ProteinsDNA Repair EnzymesMre11a protein, mouseMRE11 Homologue ProteinATMdouble-strand breaksMre11 complexRad50

Identifiers

PMID24532689
PMCPMC3950343

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.